Krka Pharmaceuticals

Krka Brand Origin and Growth

Krka, d. d., Novo mesto is one of the world's leading generic pharmaceutical companies. Founded in 1954 in Novo mesto, Slovenia (then part of Yugoslavia), it began as a small laboratory and has since evolved into a global powerhouse in the healthcare sector. The brand is deeply rooted in Slovenian industrial history and is considered a national pride due to its extensive research and development capabilities.

Manufacturing and Global Presence

Krka operates a sophisticated manufacturing network focused on producing high-quality generic prescription pharmaceuticals, non-prescription products (OTC), and animal health products. While the bulk of its high-tech production remains in Slovenia, the company has expanded its manufacturing footprint to include facilities in Poland, Germany, Croatia, and the Russian Federation to better serve regional markets and optimize its supply chain.

Ownership and Corporate Structure

Krka is a public joint-stock company listed on the Ljubljana Stock Exchange and the Warsaw Stock Exchange. Unlike many pharmaceutical brands that have been acquired by larger conglomerates, Krka has maintained its independence. Its ownership structure is diverse, consisting of various institutional investors, state-owned funds (such as Slovenian Sovereign Holding), and individual shareholders. This independence allows Krka to dictate its global strategy from its headquarters in Novo mesto.